No Detail Found!

The differential regulation of tumor suppressor genes (SAMD9, SPRED1, TGFBI, DUSP6, CDX2, TP53) and MAPK/ERK signaling pathway in colorectal cancer

Author(s)
Mahmood Rasool Center of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences, King Abdulaziz University,Jeddah,Saudi Arabia
Khalid I Alhassan Department of Biological Science, King Abdulaziz University,Jeddah,Saudi Arabia
Sajjad Karim Center of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences, King Abdulaziz University,Jeddah,Saudi Arabia
Absarul Haque King Fahd Medical Research Center, Faculty of Applied Medical Sciences, King Abdulaziz University,Jeddah,Saudi Arabia
Mohammed HZ Mutwakil Department of Biological Science, King Abdulaziz University,Jeddah,Saudi Arabia
Mohammed Alharthi Faculty of Medicine, King Abdulaziz University Hospital, King Abdulaziz University,Jeddah,Saudi Arabia
Adeel G Chaudhary Center of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences, King Abdulaziz University,Jeddah,Saudi Arabia
Peter Natesan Pushparaj Center of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences, King Abdulaziz University,Jeddah,Saudi Arabia
Abstract
Despite considerable advancements in research, particularly in oncology, colorectal cancer (CRC) remains a formidable and deadly disease. It is crucial to delve deeper into the effects of targeted therapies, signaling pathways, and genetic regulation to ensure the effectiveness of cancer treatments. In this study, we obtained microarray data for four patient-derived CRC organoids from the Gene Expression Omnibus (GEO) database (accession number: GSE114060). We then used several nextgeneration knowledge discovery (NGKD) tools, such as GEO2R, Metascape, WebGestalt, and Ingenuity Pathway Analysis (IPA) software, to investigate the underlying molecular mechanisms in colorectal cancer-derived organoids treated with trametinib compared to those treated with DMSO. Our NGKD analysis revealed upregulation of SAMD, TP53, and SPTLC3 and downregulation of SPRED1, TGFBI, and DUSP6. The MAPK/ERK signaling pathway was significantly downregulated and was associated with reduced expression of CDX2 in CRC organoids treated with trametinib. We concluded that SAMD9, SPRED1, TGFBI, TP53, and DUSP6 are differentially regulated and can play a pivotal role in the downregulation of the MAPK/ERK signaling pathway to suppress CRC. The use of targeted therapies to regulate the specific gene signatures identified in the current study may be beneficial in the CRC associated tumor suppression . On the other hand, upregulation of SPTLC3 may be induced by MEK inhibitors and may cause hepatotoxicity alongside nonalcoholic steatohepatitis.
Publication Details
Page(s) 1-11
Published Journal: Asian Journal of Agriculture and Biology, Volume: 4, Issue: 0, Year: 2024

Request the full text from PASTIC

Keywords
Hepatotoxicity, Organoids, tumor suppression, colorectal cancer, MEK inhibitor, signaling pathway
References
Aasebø K,Dragomir A,Sundström M,Mezheyeuski A,Edqvist PH,Eide GE,Ponten F,Pfeiffer P,Glimelius B,Sorbye H .2020 .CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup. , 11(10) : 8.
.2020 .. , 00008 : .
Ablain J,Liu S,Moriceau G,Lo RS,Zon LI,Aubrey BJ,Strasser A,Kelly GL .2016 .TumorSuppressor Functions of the TP53 Pathway. Perspect. Med, 6(5) : .
Balbinot C,Armant O,Elarouci N,Marisa L,Martin E,De Clara E,Onea A,Deschamps J,Beck F,Freund JN,Duluc I .2018 .The Cdx2 homeobox gene suppresses intestinal tumorigenesis through non-cell-autonomous mechanisms. J. Exp. Med, 215(3) : 911-926.
Chen Y,Zhao H,Feng Y,Ye Q,Hu J,Guo Y,Feng Y .2021 .Pan-Cancer Analysis of the Associations of TGFBI Expression With Prognosis and Immune Characteristics. Mol. Biosci, 745649 : .
Cho SB .2022 .Uncovering Oncogenic Mechanisms of Tumor Suppressor Genes in Breast Cancer Multi-Omics Data. Int. J. Mol. Sci, 23(17) : 9624.
Dalerba P,Sahoo D,Paik S,Guo X,Yothers G,Song N,Wilcox-Fogel N,Forgó E,Rajendran PS,Miranda SP,Hisamori S,Hutchison J,Kalisky T,Qian D,Wolmark N,Fisher GA,Clarke MF .2016 .CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer. New Engl. J. Med, 374(3) : 211-22.
De S,Campbell C,Venkitaraman AR,Esposito A .2020 .Pulsatile MAPK Signaling Modulates p53 Activity to Control Cell Fate Decisions at the G2 Checkpoint for DNA Damage. Cell Rep, 01(7) : 2083-2093.
. .. , : .
Guo YJ,Pan WW,Liu SB,Shen ZF,Xu Y,Hu LL .2020 .ERK/MAPK signaling pathway and tumorigenesis. Exp. Ther. Med, 8454 : 1997-2007.
Ijuin S,Oda K,Mawatari S,Taniyama O,Toyodome A,Sakae H,Tabu K,Kumagai K,Kanmura S,Tamai T,Moriuchi A,Uto H,Ido A,mco A .2021 .Serine palmitoyltransferase long chain subunit 3 is associated with hepatocellular carcinoma in patients with NAFLD. Mol. Clin. Oncol. (2), 2488 : 55.
Kanda Y,Mizuno A,Takasaki T,Satoh R,Hagihara K,Masuko T,Endo Y,Tanabe G,Sugiura R .2021 .Down-regulation of dual-specificity phosphatase 6, a negative regulator of oncogenic ERK signaling, by ACA-28 induces apoptosis in NIH/3T3 cells overexpressing HER2/ErbB2. Genes Cells. (2. , : 109-116.
Krueger F,Madeja Z,Hemberger M,McMahon M,Cook SJ,Gaunt SJ .2009 .Down-regulation of Cdx2 in colorectal carcinoma cells by the RafMEK-ERK 1/2 pathway. Cell Signal, 07 : 1846-56.
Lee CL,Cremona M,Farrelly A,Workman JA,Kennedy S,Aslam R,Carr A,Madden S,O'Neill B,Hennessy BT,Toomey S .2023 .Preclinical evaluation of the CDK4/6 inhibitor palbociclib in combination with a PI3K or MEK inhibitor in colorectal cancer. Cancer Biol. Ther, 24(1) : 2223388.
.2023 .. , 2223388 : .
Liao Y,Wang J,Jaehnig EJ,Shi Z,Zhang B .2019 .WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res, 47(W1) : W199-W205.
. .. , : .
Ma J,Yu X,Guo L,Lu SH .2013 .DUSP6, a tumor suppressor, is involved in differentiation and apoptosis in esophageal squamous cell carcinoma. Oncol. Lett, 1605 : 1624-1630.
Pajares MJ,Agorreta J,Salvo E,Behrens C,Wistuba II,Montuenga LM,Pio R,Rouzaut A .2014 .TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients. Brit. J. Cancer, 33(6) : 1545-51.
Peng S,Meng X,Zhang F,Pathak PK,Chaturvedi J,Coronado J,Morales M,Mao Y,Qian SB,Deng J,Xiang Y .2022 .Structure and function of an effector domain in antiviral factors and tumor suppressors SAMD9 and SAMD9L. Proc. Natl. Acad. Sci. USA, 119(4) : .
Price KAR,Warsame R,O'Shea M,Kim Y,Ellingson SA,Asiedu GB .2023 .A MixedMethod Approach to Explore Successful Recruitment and Treatment of Minority Patients on Therapeutic Cancer Clinical Trials at a Tertiary Referral Center Using Photo-Elicitation Interviews. Health Equity, 0170(1) : 117-127.
Brugge Sever R,JS Sever R .2015 .Signal transduction in cancer. Cold Spring Harb. Perspect. Med, 5(4) : a006098.
. .. , : .
Welsh SJ,Corrie PG .2015 .Management of BRAF and MEK inhibitor toxicities in patients with metastatic melanoma. Ther. Adv. Med, 2 : 122-36.
Wong JC,Bryant V,Lamprecht T,Ma J,Walsh M,Schwartz J,Del Pilar Alzamora M,Mullighan CG,Loh ML,Ribeiro R,Downing JR,Carroll WL,Davis J,Gold S,Rogers PC,Israels S,Yanofsky R,Shannon K,Klco JM .2018 .Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes. JCI Insight, 121086(14) : .
Yeh LT,Lin CW,Lu KH,Hsieh YH,Yeh CB,Yang SF,Yang JS .2022 .Niclosamide Suppresses Migration and Invasion of Human Osteosarcoma Cells by Repressing TGFBI Expression via the ERK Signaling Pathway. Int. J. Mol. Sci, 23(1) : 484.
Yip HYK,Papa A .2021 .. Combinatorial Treatments, and New Developments. Cells, 10(3) : 659.
Zhan T,Ambrosi G,Wandmacher AM,Rauscher B,Betge J,Rindtorff N,Häussler RS,Hinsenkamp I,Bamberg L,Hessling B,Müller-Decker K,Erdmann G,Burgermeister E,Ebert MP,Boutros M .2019 .MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer. Nat. Commun, 10(1) : 2197.
Zhang R,Zhang Y,Lu X,Xu W,Wang H,Mo W,Pang H,Tang R,Li S,Yan X,Li Y .2020 .SPRED1 Is Downregulated and a Prognostic Biomarker in Adult Acute Myeloid Leukemia. Front. Oncol, 00204 : .
Zhao M,Sun J,Zhao Z .2013 .TSGene: a web resource for tumor suppressor genes. Nucleic Acids Res, 41 : D970-6.
Zhao M,Kim P,Mitra R,Zhao J,Zhao Z .2016 .TSGene 2.0: an updated literature-based knowledgebase for tumor suppressor genes. Nucleic Acids Res, 44(D1) : D1023-31.
Zhou Y,Zhou B,Pache L,Chang M,Khodabakhshi AH,Tanaseichuk O,Benner C,Chanda SK .2019 .Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun, 10(1) : 1523.
0

Citations

0

Downloads

11

Views